NPPA: Six paracetamol API manufacturers to export half of monthly production

The National Pharmaceutical Pricing Authority (NPPA) has grantedt nod to six major manufacturers for exporting 50 per cent of their monthly operating capacity of paracetamol active pharmaceutical ingredient (API) subject to similar quantity for domestic market.
An undertaking is required to be submitted to Directorate General of Foreign Trade (DGFT) in this regard at the time of export by Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceuticals, Granules India Ltd, Bharat Chemicals and Para Products Pvt Ltd.
A request has also been made to Drugs Controller General of India (DCGI) by NPPA for reserving the quantity for domestic requirement.

State and Union territory drugs controller have been asked by the DCGI to email details of action taken and report of compliance by manufacturer along with data in this regard on fortnightly basis (i.e. on 15th and 30th of every month on enforcecell.div@cdsco.nic.in, import.regist@cdsco.nic.in and dci@nic.in till NPPA’s subject order remains operational in light of COVID-19.

The capacity of some of the manufacturers have been explained as follows:-
Sri Krishna Pharmaceuticals, Hyderabad has installed capacity of 12,000 million tonnes per annum.

Hyderabad based Granules India Ltd has the capacity to manufacture paracetamol API of 1,800 tonnes monthly and 22,000 tonnes annually.

Gujarat Farmson Pharmaceuticals, Nandesari in Vadodara has manufacturing capacity in excess of 25,000 metric tonnes annually.

Meghmani LLP at Dahej has built up a manufacturing unit with a capacity of 7,500 metric tonnes of paracetamol per annum.
Bharat Chemicals at Korba, Chhatisgarh, has a yearly production capacity of nearly 4,000 metric tonnes of paracetamol.

The NPPA had allowed six manufacturers to export 2,000 metric tonnes of paracetamol API based on recommendation by the ministry of external affairs.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • Health
    • June 11, 2025
    • 487 views
    Doctors trialling ‘poo pills’ to flush out dangerous superbugs

    UK doctors are attempting to clear dangerous superbug infections using “poo pills” containing freeze-dried faeces. The stool samples come from healthy donors and are packed with good bacteria. Early data…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July